S: Susceptible
I: Infected
D: Diagnosed
A: Ailing
R: Recognized
T: Threatened
H: Healed
E: Extinct
Susceptible: susceptible to infection
Exposed: exposed to infection
Infectious: infected with the virus
Removed: recovered from the virus
Risk Perception: the effect of risk perception on the spread of the virus
Cumulative Cases: the total number of cases
Dead Individuals: individuals who have died from the virus
Clinical Severity: the clinical severity of COVID-19
Stochastic Transmission: transmission dynamics of the virus
Basic Reproduction Number: estimated number of transmissions
SIR model: model for human-to-human transmission
SEIR model: model considering risk perception and cumulative number of cases
SIDARTHE model: model predicting the evolution of epidemics
Lockdown: strategy to contain the spread of the infection
Testing: important to detect undetected infected people
R0: basic reproduction number
S: susceptible (uninfected)
I: infected (asymptomatic or pauci-symptomatic infected, undetected)
D: diagnosed (asymptomatic infected, detected)
A: ailing (symptomatic infected, undetected)
R: recognized (symptomatic infected, detected)
T: threatened (infected with life-threatening symptoms, detected)
H: healed (recovered)
E: extinct (dead)
R0: basic reproduction number
R1.66: social distancing, awareness of the epidemic, hygiene and behavioral recommendations
R1.80: screening focused on symptomatic individuals
R1.60: partially incomplete lockdown effectiveness 
None
R0: Reproduction number of the virus
SOI: Severity of Infection classification
CFR: Case Fatality Rate
None
Cumulative infected: Total number of infected people
Current total infected: Number of currently infected people
Recovered: Number of people who have recovered from the virus
Deaths: Number of people who have died from the virus
Diagnosed cumulative infected: Total number of people diagnosed as infected
Diagnosed current total infected: Number of people currently diagnosed as infected
Diagnosed recovered: Number of people who have been diagnosed as recovered
CFR: Ratio of deaths to total number of infected people
CFR: mortality coefficient 
ICUs: insufficient number of ICUs 
lockdown measures: control measures of varying strength and nature 
transmission rate: estimated transmission rate 
diagnosis campaigns: campaigns to detect SARS-CoV-2 immunoglobulins IgM and IgG
Mortality rate: number of deaths in the whole population
CFR: number of deaths in the infected population
Social restriction: measures that reduce the spread of SARS-CoV-2
Testing: extent of social restriction and testing
New drugs and vaccines: ongoing innovations
Case fatality: excess case fatality
S: fraction of population in susceptible stage
I: fraction of population in infected stage
D: fraction of population in diagnosed stage
A: fraction of population in ailing stage
R: fraction of population in recognized stage
T: fraction of population in threatened stage
H: fraction of population in hospitalized stage
E: fraction of population in expired stage
α: transmission rate due to contacts between a susceptible subject and an infected subject
β: transmission rate due to contacts between a susceptible subject and a diagnosed subject
γ: transmission rate due to contacts between a susceptible subject and an ailing subject
δ: transmission rate due to contacts between a susceptible subject and a recognized subject
ε: probability rate of detection of asymptomatic cases
ζ: probability rate at which an infected subject not aware of being infected develops clinically relevant symptoms
η: probability rate at which an infected subject aware of being infected develops clinically relevant symptoms
θ: probability rate of detection of symptomatic cases
λ: probability rate at which an infected subject not aware of being infected is diagnosed
ρ: probability rate at which an infected subject aware of being infected is diagnosed
μ: probability rate at which an ailing subject is recognized
κ: probability rate at
μ: rate at which undetected infected subjects develop life-threatening symptoms
ν: rate at which detected infected subjects develop life-threatening symptoms
τ: mortality rate for infected subjects with life-threatening symptoms
λ: rate of recovery for infected subjects
κ: rate of recovery for infected subjects
ξ: rate of recovery for infected subjects
ρ: rate of recovery for infected subjects
σ: rate of recovery for infected subjects
H(t): cumulative variable that depends on other variables and its own initial conditions
E(t): cumulative variable that depends on other variables and its own initial conditions
None
S: Susceptible individuals
I: Infected individuals
D: Infected individuals
A: Infected individuals
R: Infected individuals
T: Infected individuals
H: Healed individuals
E: Deceased individuals
u: Feedback signal
S(t): The number of susceptible individuals at time t
I(t): The number of infected individuals at time t
D(t): The number of diagnosed individuals at time t
A(t): The number of asymptomatic individuals at time t
R(t): The number of recovered individuals at time t
T(t): The number of deceased individuals at time t
F: Constant
b: Constant
R0: Reproduction number
f0: Constant
M(t): Actual CFR
P(t): Perceived CFR
ε: Constant
θ: Constant
μ: Constant
D(t): number of currently infected individuals with different SOI (asymptomatic or pauci-symptomatic, quarantined at home
R(t): symptomatic and hospitalized
T(t): symptomatic in life-threatening conditions, admitted to ICUs
E(t): number of deaths
ρD: 
ξR: 
σT: 
ϕ(t): 
I: number of diagnosed individuals who recovered
I: fraction of the population in each stage at day 1
D: fraction of the population in each stage at day 1
A: fraction of the population in each stage at day 1
R: fraction of the population in each stage at day 1
T: fraction of the population in each stage at day 1
H: fraction of the population in each stage at day 1
E: fraction of the population in each stage at day 1
S: fraction of the population in each stage at day 1
α: parameter magnitude of relative epidemiological information
β: parameter magnitude of relative epidemiological information
δ: parameter magnitude of relative epidemiological information
γ: parameter magnitude of relative epidemiological information
ε: parameter magnitude of relative epidemiological information
θ: parameter magnitude of relative epidemiological information
ζ: parameter magnitude of relative epidemiological information
η: parameter magnitude of relative epidemiological information
μ: parameter magnitude of relative epidemiological information
ν: parameter magnitude of relative epidemiological information
τ: parameter magnitude of relative epidemiological information
λ: parameter magnitude of relative epidemiological information
ρ: parameter magnitude of relative epidemiological information
κ: parameter magnitude of relative epidemiological information
ξ: parameter magnitude of
α: Infection rate 
β: Transmission rate 
γ: Recovery rate 
δ: Transmission rate 
ε: Infection rate 
θ: Testing parameter 
ζ: Testing parameter 
η: Testing parameter 
μ: Testing parameter 
ν: Testing parameter 
λ: Healing parameter 
ρ: Healing parameter 
κ: Healing parameter 
ξ: Healing parameter 
σ: Healing parameter 
τ: Healing parameter
α: Social-distancing countermeasures
γ: Social-distancing countermeasures
R0: Transmission rate
CFR: Ratio between the number of deaths ascribed to the infection and the number of diagnosed cases
α: Transmission parameters, related to lockdown measures
β: Transmission parameters, related to lockdown measures
γ: Transmission parameters, related to lockdown measures
δ: Transmission parameters, related to lockdown measures
None
α: Increases all the curves
β: Increases all the curves
γ: Increases all the curves
δ: Increases all the curves
ε: Decreases all the curves
θ: Decreases all the curves
ζ: Decreases final number of infected and recovered, increases number of deaths
η: Decreases final number of infected and recovered, increases number of deaths
μ: Decreases final number of infected and recovered, increases number of deaths
ν: Decreases final number of infected and recovered, increases number of deaths
λ: Decreases all the curves, apart from the curve of recovered patients
ρ: Decreases all the curves
κ: Decreases all the curves
ξ: Decreases all the curves
σ: Decreases all the curves
τ: Leaves all the curves almost unaffected
α: Infection coefficient
β: Infection coefficient
γ: Infection coefficient
δ: Infection coefficient
CFR: Case fatality rate
G.G., F.B. and P.C.: Authors who proposed the model and performed the mathematical derivations, the fitting and the simulations.
R.B., A.D.F., A.D.M. and M.C.: Authors who provided first-hand insight into the disease evolution and provided the clinical contextualization and interpretation of the results.
None
ECU residents: People living in the ECU area.
Intensive care unit: People in the intensive care unit.
Paediatric unit: People in the paediatric unit.
Virology staff: Staff members in the virology department.
Virology technical staff: Technical staff in the virology department.
Virology residents: Residents in the virology department.
Pharmacy unit: People in the pharmacy unit.
Hospital Leadership: Leaders of the hospital.
Data unit: People in the data unit.
χ: rate at which immunity is lost
α: transmission coefficient
β: transmission coefficient
α: Transmission coefficient
γ: Transmission coefficient
δ: Transmission coefficient
ε: Testing coefficient
θ: Testing coefficient
ζ: worsening coefficients leading to clinically relevant symptoms
η: worsening coefficients leading to clinically relevant symptoms
μ: worsening coefficients leading to life-threatening symptoms
ν: worsening coefficients leading to life-threatening symptoms
λ: healing coefficient
ρ: healing coefficients
κ: healing coefficients
ξ: healing coefficients
σ: healing coefficients
τ: mortality coefficient
None
Cohen's d: effect size
Pearson's r: effect size
Matlab R2017b: software
Italian Ministry of Health: data source
ChIP-seq: method
Flow cytometry: Technique for analyzing and sorting particles, such as cells, by measuring their light scattering and fluorescent characteristics.
Palaeontology: Study of fossils and the history of life on Earth.
MRI-based neuroimaging: Technique for imaging the structure and function of the brain using magnetic resonance imaging.
Animals and other organisms: Living organisms studied in research.
Human research participants: People who take part in research studies.
Clinical data: Data collected from medical records and other sources related to patient care.
